Publicaciones en colaboración con investigadores/as de Centro Nacional de Epidemiología (3)

2024

  1. Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1796-1802

2014

  1. Clinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendations

    PLoS ONE, Vol. 9, Núm. 3

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9